NDADENTALSOLUTIONPriority Review
Approved
Aug 1986
Lifecycle
LOE Approaching
Competitive Pressure
45/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 8h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PERIDEX is a chlorhexidine gluconate oral rinse used in dental care to reduce plaque and gingivitis. It is an antimicrobial agent that works by disrupting bacterial cell membranes in the oral cavity. The product is administered as a topical dental solution.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (45/100), suggesting potential team consolidation and transition planning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PERIDEX offers limited career growth due to approaching LOE and minimal linked job openings. Professionals joining this team should expect a focus on defending market share, managing generics transition, and optimizing profitability rather than expansion.
Brand ManagerField Sales Representative
Worked on PERIDEX at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.